Video: AI model ARTIMES outperforms physicians at evaluating treatment response in pleural mesothelioma (VIDEO)
Caption
Physicians and researchers at the Netherlands Cancer Institute have developed an AI model that outperforms physicians at evaluating treatment response in pleural mesothelioma. Being far more accurate than the current international standard criteria (RECIST), the model provides patients with greater certainty and tailored treatments. It radically changes how physicians assess tumors and could accelerate the development of new treatments by making clinical trials more reliable and efficient.
Credit
@Netherlands Cancer Institute
Usage Restrictions
Only to be used in context of ARTIMES model and related research.
License
Original content